Site Search
Professionals 726 results
Capabilities 89 results
Practice Area
Practice Area
As society and business become even more digitalized, technology and intellectual property (IP) have become key focal points for businesses. Our Technology Antitrust Group combines the cross-practice and cross-office experience of our lawyers to assist clients in successfully navigating the dynamic convergence of technology, antitrust, and IP law. We understand the challenges presented by the ever-changing digital landscape and are committed to providing our clients with tailored solutions to address their specific needs.
Experience 599 results
Experience
|October 10, 2025
Winston Advises Vistria Affiliate in $136M IPO of Phoenix Education Partners
A Winston & Strawn LLP team led by partners Keerthika Subramanian, Steve Gavin and Timothy Kincaid and including Jacob Tabman, Jeremy Spankowski and Jenna Smith advised TVG-I-E-AEG Holdings, LP, an affiliate of The Vistria Group, as one of the selling stockholders in the $136 million initial public offering of Phoenix Education Partners, Inc. (NYSE: PXED), the parent company of The University of Phoenix, Inc. The IPO valued Phoenix Education Partners, Inc. at approximately $1.35 billion. The transaction marks The University of Phoenix’s return to public markets after nearly a decade as a private company.
Experience
|September 29, 2025
Winston Advises PJT Partners in Beyond Meat’s $1.105 Billion Exchange Offer
Winston & Strawn LLP represented PJT Partners in its role as dealer manager to Beyond Meat, Inc., a publicly traded food technology company and leading producer of plant-based meat alternatives, in connection with an exchange offer and consent solicitation for any and all of its $1.105 billion of 0% Convertible Senior Notes due 2027 for up to $202.5 million in new 7.00% Convertible Senior Secured Second Lien PIK Toggle Notes due 2030 and up to approximately 326 million shares of common stock.
Experience
|September 23, 2025
Denali Capital Acquisition Corp Closes Business Combination with Semnur Pharmaceuticals
Winston & Strawn LLP represented Denali Capital Acquisition Corp. (OTCQB: DNQAF), a special purpose acquisition company, in the closing of its previously announced business combination with Semnur Pharmaceuticals, Inc., a clinical late-stage specialty pharmaceutical company focused on the development and commercialization of novel non-opioid pain therapies and a majority-owned subsidiary of Scilex Holding Company (Nasdaq: SCLX).
Insights & News 8,722 results
Sponsorship
|November 20, 2025
Winston & Strawn Sponsors 2025 Smart Business Dealmakers South Florida M&A Conference
Winston & Strawn is proud to sponsor the upcoming Smart Business Dealmakers South Florida M&A Conference. The conference brings together hundreds of local dealmakers, including middle-market CEOs, top investors and lenders, and leading M&A advisers.
Seminar/CLE
|November 13, 2025
AI in Action: Legal Strategies for Healthcare Innovation
We are bringing together stakeholders across the healthcare ecosystem—from front-line providers to financial backers—for a panel discussion on AI in healthcare.
Sponsorship
|November 12, 2025
Winston & Strawn Sponsors 2025 Smart Business Dealmakers Houston M&A Conference
Winston & Strawn is proud to sponsor the upcoming Smart Business Dealmakers Houston M&A Conference. The conference will discuss topics ranging from raising capital to alternative asset investing, covering the breadth of the M&A landscape.
Other Results 136 results
Site Content
What Is the National Advertising Division (NAD)?
As part of the independent, non-profit BBB National Programs, the National Advertising Division (NAD) independently evaluates the truth and accuracy of national advertising. It also works to increase the public’s confidence in advertising. NAD assesses a broad scope of ad claims, including those related to product performance, surveys, pricing, and guarantees. NAD responsibilities include:
Site Content
Also known as maritime cabotage laws, U.S. coastwise laws reserve U.S. domestic maritime trade to qualified U.S. registered (referred to as “U.S.-flag” vessels). These laws are also commonly referred to as the Jones Act. One of these coastwise laws, the Passenger Vessel Services Act, reserves the transportation of passengers between U.S. ports, or points, to qualified U.S.-flag vessels.
Law Glossary
Where Is a List of Biosimilar Drugs and Biologics That Have Been Approved in the U.S.?
The FDA maintains a list of biosimilar drugs that have been approved in the USA. This list can be found here.